Aurinia Pharmaceuticals (AUPH) Jefferies 2024 Global Healthcare Conference Summary
Aurinia Pharmaceuticals presented a summary of its performance and outlook at the Jefferies 2024 Global Healthcare Conference. The company reported strong LUPKYNIS revenue growth, projecting to be cash flow positive in Q2, and highlighted efforts in market development, patient engagement, and product differentiation. Aurinia …
AUPH
main company
Sharemaestro market context
Trend signal active
52 weeks +26.1% · Next-week setup positive 55.9%